{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:38:28Z","timestamp":1787168308784,"version":"build-2736575974"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s00392-025-02618-3","type":"journal-article","created":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T11:25:52Z","timestamp":1740482752000},"page":"1049-1058","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Clinical outcomes after complex and high-risk percutaneous coronary intervention according to baseline chronic kidney disease"],"prefix":"10.1007","volume":"114","author":[{"given":"Francesca Maria","family":"Di Muro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Sartori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Gitto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Oliva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakash","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Bay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Sweeny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parasuram","family":"Krishnamoorthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Dangas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annapoorna","family":"Kini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samin","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxana","family":"Mehran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,25]]},"reference":[{"issue":"1","key":"2618_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.kisu.2021.11.003","volume":"12","author":"CP Kovesdy","year":"2022","unstructured":"Kovesdy CP (2022) Epidemiology of chronic kidney disease: an update 2022. Kidney Int Suppl 12(1):7\u201311. https:\/\/doi.org\/10.1016\/j.kisu.2021.11.003","journal-title":"Kidney Int Suppl"},{"issue":"14","key":"2618_CR2","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1016\/j.jacc.2019.08.1017","volume":"74","author":"MJ Sarnak","year":"2019","unstructured":"Sarnak MJ, Amann K, Bangalore S et al (2019) Chronic kidney disease and coronary artery disease: JACC state-of-the-art review. J Am Coll Cardiol 74(14):1823\u20131838. https:\/\/doi.org\/10.1016\/j.jacc.2019.08.1017","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"2618_CR3","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0735-1097(02)02663-3","volume":"41","author":"G Manjunath","year":"2003","unstructured":"Manjunath G, Tighiouart H, Ibrahim H et al (2003) Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol 41(1):47\u201355. https:\/\/doi.org\/10.1016\/S0735-1097(02)02663-3","journal-title":"J Am Coll Cardiol"},{"issue":"9731","key":"2618_CR4","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","volume":"375","author":"Chronic Kidney Disease Prognosis Consortium","year":"2010","unstructured":"Chronic Kidney Disease Prognosis Consortium (2010) Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 375(9731):2073\u20132081. https:\/\/doi.org\/10.1016\/S0140-6736(10)60674-5","journal-title":"Lancet"},{"issue":"7","key":"2618_CR5","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s00392-019-01575-y","volume":"109","author":"SS Scholz","year":"2020","unstructured":"Scholz SS, Lauder L, Ewen S et al (2020) One-year clinical outcomes in patients with renal insufficiency after contemporary PCI: data from a multicenter registry. Clin Res Cardiol 109(7):845\u2013856. https:\/\/doi.org\/10.1007\/s00392-019-01575-y","journal-title":"Clin Res Cardiol"},{"issue":"3","key":"2618_CR6","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s00109-021-02037-7","volume":"99","author":"P D\u00fcsing","year":"2021","unstructured":"D\u00fcsing P, Zietzer A, Goody PR et al (2021) Vascular pathologies in chronic kidney disease: pathophysiological mechanisms and novel therapeutic approaches. J Mol Med 99(3):335\u2013348. https:\/\/doi.org\/10.1007\/s00109-021-02037-7","journal-title":"J Mol Med"},{"issue":"1","key":"2618_CR7","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jcin.2021.09.039","volume":"15","author":"M Protty","year":"2022","unstructured":"Protty M, Sharp ASP, Gallagher S et al (2022) Defining percutaneous coronary intervention complexity and risk: an analysis of the United Kingdom BCIS database 2006\u20132016. JACC Cardiovasc Interv 15(1):39\u201349. https:\/\/doi.org\/10.1016\/j.jcin.2021.09.039","journal-title":"JACC Cardiovasc Interv"},{"issue":"9","key":"2618_CR8","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.jcin.2023.02.005","volume":"16","author":"G Khandelwal","year":"2023","unstructured":"Khandelwal G, Spirito A, Tanner R et al (2023) Validation of UK-BCIS CHIP score to predict 1-year outcomes in a contemporary United States population. JACC Cardiovasc Interv 16(9):1011\u20131020. https:\/\/doi.org\/10.1016\/j.jcin.2023.02.005","journal-title":"JACC Cardiovasc Interv"},{"issue":"11","key":"2618_CR9","doi-asserted-by":"publisher","first-page":"825","DOI":"10.7326\/0003-4819-158-11-201306040-00007","volume":"158","author":"PE Stevens","year":"2013","unstructured":"Stevens PE, Levin A (2013) Evaluation and management of chronic kidney disease: synopsis of the kidney disease\u2014improving global outcomes 2012 clinical practice guideline. Ann Intern Med 158(11):825\u2013830. https:\/\/doi.org\/10.7326\/0003-4819-158-11-201306040-00007","journal-title":"Ann Intern Med"},{"issue":"20","key":"2618_CR10","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","author":"World Medical Association","year":"2013","unstructured":"World Medical Association (2013) World medical association declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 310(20):2191\u20132194. https:\/\/doi.org\/10.1001\/jama.2013.281053","journal-title":"JAMA"},{"issue":"16","key":"2618_CR11","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1016\/j.jacc.2012.08.001","volume":"60","author":"K Thygesen","year":"2012","unstructured":"Thygesen K, Alpert JS, Jaffe AS et al (2012) Third universal definition of myocardial infarction. J Am Coll Cardiol 60(16):1581\u20131598. https:\/\/doi.org\/10.1016\/j.jacc.2012.08.001","journal-title":"J Am Coll Cardiol"},{"issue":"10315","key":"2618_CR12","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1016\/S0140-6736(21)02326-6","volume":"398","author":"R Mehran","year":"2021","unstructured":"Mehran R, Owen R, Chiarito M et al (2021) A contemporary simple risk score for prediction of contrast-associated acute kidney injury after percutaneous coronary intervention: derivation and validation from an observational registry. The Lancet 398(10315):1974\u20131983. https:\/\/doi.org\/10.1016\/S0140-6736(21)02326-6","journal-title":"The Lancet"},{"issue":"4","key":"2618_CR13","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","volume":"105","author":"PE Stevens","year":"2024","unstructured":"Stevens PE, Ahmed SB, Carrero JJ et al (2024) KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int 105(4):S117\u2013S314. https:\/\/doi.org\/10.1016\/j.kint.2023.10.018","journal-title":"Kidney Int"},{"issue":"3","key":"2618_CR14","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1093\/ejcts\/ezx104","volume":"52","author":"M Milojevic","year":"2017","unstructured":"Milojevic M, Head SJ, Mack MJ et al (2017) Influence of practice patterns on outcome among countries enrolled in the SYNTAX trial: 5-year results between percutaneous coronary intervention and coronary artery bypass grafting\u2020. Eur J Cardiothorac Surg 52(3):445\u2013453. https:\/\/doi.org\/10.1093\/ejcts\/ezx104","journal-title":"Eur J Cardiothorac Surg"},{"issue":"17","key":"2618_CR15","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1016\/j.jacc.2016.07.760","volume":"68","author":"G Giustino","year":"2016","unstructured":"Giustino G, Chieffo A, Palmerini T et al (2016) Efficacy and safety of dual antiplatelet therapy after complex PCI. J Am Coll Cardiol 68(17):1851\u20131864. https:\/\/doi.org\/10.1016\/j.jacc.2016.07.760","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"2618_CR16","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1002\/ccd.30569","volume":"101","author":"H Chen","year":"2023","unstructured":"Chen H, Spirito A, Sartori S et al (2023) Impact of complex percutaneous coronary intervention features on clinical outcomes in patients with or without chronic kidney disease. Catheter Cardiovasc Interv 101(3):511\u2013519. https:\/\/doi.org\/10.1002\/ccd.30569","journal-title":"Catheter Cardiovasc Interv"},{"issue":"11","key":"2618_CR17","doi-asserted-by":"publisher","first-page":"e2345554","DOI":"10.1001\/jamanetworkopen.2023.45554","volume":"6","author":"W Kwon","year":"2023","unstructured":"Kwon W, Choi KH, Song YB et al (2023) Intravascular imaging in patients with complex coronary lesions and chronic kidney disease. JAMA Netw Open 6(11):e2345554\u2013e2345554. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.45554","journal-title":"JAMA Netw Open"},{"key":"2618_CR18","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ahj.2022.02.006","volume":"248","author":"WW O\u2019Neill","year":"2022","unstructured":"O\u2019Neill WW, Anderson M, Burkhoff D et al (2022) Improved outcomes in patients with severely depressed LVEF undergoing percutaneous coronary intervention with contemporary practices. Am Heart J 248:139\u2013149. https:\/\/doi.org\/10.1016\/j.ahj.2022.02.006","journal-title":"Am Heart J"},{"issue":"12","key":"2618_CR19","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.2215\/CJN.04320709","volume":"4","author":"S Nakamura","year":"2009","unstructured":"Nakamura S, Ishibashi-Ueda H, Niizuma S, Yoshihara F, Horio T, Kawano Y (2009) Coronary calcification in patients with chronic kidney disease and coronary artery disease. Clin J Am Soc Nephrol 4(12):1892\u20131900","journal-title":"Clin J Am Soc Nephrol"},{"issue":"8","key":"2618_CR20","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1093\/ndt\/gft103","volume":"28","author":"T Gremmel","year":"2013","unstructured":"Gremmel T, M\u00fcller M, Steiner S et al (2013) Chronic kidney disease is associated with increased platelet activation and poor response to antiplatelet therapy. Nephrol Dial Transplant 28(8):2116\u20132122. https:\/\/doi.org\/10.1093\/ndt\/gft103","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"2618_CR21","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.115.001683","volume":"8","author":"U Baber","year":"2015","unstructured":"Baber U, Mehran R, Kirtane AJ et al (2015) Prevalence and impact of high platelet reactivity in chronic kidney disease. Circ Cardiovasc Interv 8(6):e001683. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.115.001683","journal-title":"Circ Cardiovasc Interv"},{"issue":"1","key":"2618_CR22","doi-asserted-by":"publisher","first-page":"155","DOI":"10.2215\/CJN.04100321","volume":"17","author":"CCFMJ Baaten","year":"2022","unstructured":"Baaten CCFMJ, Schr\u00f6er JR, Floege J et al (2022) Platelet abnormalities in CKD and their implications for antiplatelet therapy. Clin J Am Soc Nephrol 17(1):155\u2013170","journal-title":"Clin J Am Soc Nephrol"},{"issue":"8","key":"2618_CR23","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1161\/CIRCRESAHA.123.321752","volume":"132","author":"CCFMJ Baaten","year":"2023","unstructured":"Baaten CCFMJ, Vondenhoff S, Noels H (2023) Endothelial cell dysfunction and increased cardiovascular risk in patients with chronic kidney disease. Circ Res 132(8):970\u2013992. https:\/\/doi.org\/10.1161\/CIRCRESAHA.123.321752","journal-title":"Circ Res"},{"key":"2618_CR24","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ijcard.2019.04.043","volume":"290","author":"L Azzalini","year":"2019","unstructured":"Azzalini L, Poletti E, Lombardo F et al (2019) Risk of contrast-induced nephropathy in patients undergoing complex percutaneous coronary intervention. Int J Cardiol 290:59\u201363. https:\/\/doi.org\/10.1016\/j.ijcard.2019.04.043","journal-title":"Int J Cardiol"},{"issue":"16","key":"2618_CR25","doi-asserted-by":"publisher","first-page":"4931","DOI":"10.3390\/jcm13164931","volume":"13","author":"FM Di Muro","year":"2024","unstructured":"Di Muro FM, Bellino M, Esposito L et al (2024) Role of mechanical circulatory support in complex high-risk and indicated percutaneous coronary intervention: current indications, device options, and potential complications. J Clin Med 13(16):4931. https:\/\/doi.org\/10.3390\/jcm13164931","journal-title":"J Clin Med"},{"issue":"2","key":"2618_CR26","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.cjca.2015.05.013","volume":"32","author":"L Azzalini","year":"2016","unstructured":"Azzalini L, Spagnoli V, Ly HQ (2016) Contrast-induced nephropathy: from pathophysiology to preventive strategies. Can J Cardiol 32(2):247\u2013255. https:\/\/doi.org\/10.1016\/j.cjca.2015.05.013","journal-title":"Can J Cardiol"},{"issue":"22","key":"2618_CR27","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1056\/NEJMra1805256","volume":"380","author":"R Mehran","year":"2019","unstructured":"Mehran R, Dangas GD, Weisbord SD (2019) Contrast-associated acute kidney injury. N Engl J Med 380(22):2146\u20132155. https:\/\/doi.org\/10.1056\/NEJMra1805256","journal-title":"N Engl J Med"},{"issue":"5","key":"2618_CR28","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1253\/circj.CJ-21-0905","volume":"86","author":"K Shibata","year":"2022","unstructured":"Shibata K, Wakabayashi K, Ishinaga T et al (2022) Feasibility, safety, and long-term outcomes of zero-contrast percutaneous coronary intervention in patients with chronic kidney disease. Circ J 86(5):787\u2013796. https:\/\/doi.org\/10.1253\/circj.CJ-21-0905","journal-title":"Circ J"},{"issue":"17","key":"2618_CR29","doi-asserted-by":"publisher","first-page":"e1371","DOI":"10.4244\/EIJ-D-21-00904","volume":"17","author":"JD Angiolillo","year":"2022","unstructured":"Angiolillo JD, Galli M, Collet J-P, Kastrati A, O\u2019Donoghue LM (2022) Antiplatelet therapy after percutaneous coronary intervention. EuroIntervention 17(17):e1371\u2013e1396","journal-title":"EuroIntervention"},{"issue":"2","key":"2618_CR30","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/s41569-021-00598-1","volume":"19","author":"D Capodanno","year":"2022","unstructured":"Capodanno D, Bhatt DL, Gibson CM et al (2022) Bleeding avoidance strategies in percutaneous coronary intervention. Nat Rev Cardiol 19(2):117\u2013132. https:\/\/doi.org\/10.1038\/s41569-021-00598-1","journal-title":"Nat Rev Cardiol"},{"issue":"7","key":"2618_CR31","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.jacc.2018.11.048","volume":"73","author":"F Costa","year":"2019","unstructured":"Costa F, Van Klaveren D, Feres F et al (2019) Dual antiplatelet therapy duration based on ischemic and bleeding risks after coronary stenting. J Am Coll Cardiol 73(7):741\u2013754. https:\/\/doi.org\/10.1016\/j.jacc.2018.11.048","journal-title":"J Am Coll Cardiol"},{"key":"2618_CR32","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.ijcard.2019.05.065","volume":"293","author":"A Chieffo","year":"2019","unstructured":"Chieffo A, Burzotta F, Pappalardo F et al (2019) Clinical expert consensus document on the use of percutaneous left ventricular assist support devices during complex high-risk indicated PCI. Int J Cardiol 293:84\u201390. https:\/\/doi.org\/10.1016\/j.ijcard.2019.05.065","journal-title":"Int J Cardiol"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-025-02618-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00392-025-02618-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-025-02618-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T06:32:56Z","timestamp":1757140376000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00392-025-02618-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,25]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["2618"],"URL":"https:\/\/doi.org\/10.1007\/s00392-025-02618-3","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,25]]},"assertion":[{"value":"20 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Bay is supported by a grant from the German Heart Foundation (grant number S\/06\/23). Dr. Dr. Mehran reports institutional research grants from Abbott Laboratories, Abiomed, Applied Therapeutics, AstraZeneca, Bayer, Beth Israel Deaconess, Bristol Myers Squibb, CERC, Chiesi, Concept Medical, CSL Behring, DSI, Medtronic, Novartis Pharmaceuticals, OrbusNeich; consultant fees from Abbott Laboratories, Boston Scientific, Janssen Scientific Affairs, Medscape\/WebMD, Medtelligence (Janssen Scientific Affairs), Roivant Sciences, Sanofi, Siemens Medical Solutions; consultant fees paid to the institution from Abbott Laboratories, Bristol-Myers Squibb; advisory board, funding paid to the institution from Spectranetics\/Philips\/Volcano Corp; consultant (spouse) from Abiomed, The Medicines Company, Merck; Equity\u2009<\u20091% from Claret Medical, Elixir Medical; DSMB Membership fees paid to the institution from Watermark Research Partners; consulting (no fee) from Idorsia Pharmaceuticals Ltd., Regeneron Pharmaceuticals. Associate Editor for ACC, AMA.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}